Blueberries Medical Corp.
BBRRF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $471 | $288 | $235 | $139 |
| % Growth | 63.5% | 22.4% | 69.7% | – |
| Cost of Goods Sold | $307 | $204 | $253 | $384 |
| Gross Profit | $165 | $84 | -$18 | -$245 |
| % Margin | 34.9% | 29.2% | -7.5% | -176.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $904 | $1,221 | $1,226 | $533 |
| SG&A Expenses | $904 | $1,311 | $1,229 | $579 |
| Sales & Mktg Exp. | $0 | $90 | $4 | $46 |
| Other Operating Expenses | $174 | $150 | $394 | $136 |
| Operating Expenses | $1,078 | $1,461 | $1,623 | $715 |
| Operating Income | -$913 | -$1,376 | -$1,344 | -$961 |
| % Margin | -193.7% | -477.4% | -570.9% | -692.5% |
| Other Income/Exp. Net | -$235 | -$259 | -$124 | -$4,186 |
| Pre-Tax Income | -$1,149 | -$1,635 | -$1,468 | -$5,147 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1,149 | -$1,635 | -$1,468 | -$5,147 |
| % Margin | -243.6% | -567.3% | -623.4% | -3,709.6% |
| EPS | -0.003 | -0.008 | -0.009 | -0.035 |
| % Growth | 61.3% | 13.8% | 74.9% | – |
| EPS Diluted | -0.003 | -0.008 | -0.009 | -0.035 |
| Weighted Avg Shares Out | 399,025 | 219,299 | 168,887 | 148,505 |
| Weighted Avg Shares Out Dil | 399,025 | 219,299 | 168,887 | 148,505 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $264 | $360 | $269 |
| Depreciation & Amortization | $105 | $150 | $292 | $704 |
| EBITDA | -$1,043 | -$1,222 | -$1,349 | -$1,085 |
| % Margin | -221.3% | -423.8% | -572.9% | -781.9% |